SpringWorks Therapeutics Inc (NAS:SWTX)
$ 34.76 1.66 (5.02%) Market Cap: 2.58 Bil Enterprise Value: 2.10 Bil PE Ratio: 0 PB Ratio: 4.63 GF Score: 40/100

SpringWorks Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 12:30PM GMT
Release Date Price: $66.9 (+1.81%)
Anupam Rama
JPMorgan Chase & Co, Research Division - VP and Analyst

All right. Welcome everyday -- everyone to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama, and I'm one of the senior biotech analysts her at JPMorgan. I'm joined by Matt Bannon Tessa Romero from the team. And first presenting company of the day is SpringWorks, and presenting on behalf of the company, we have CEO, Saqib Islam.

Before I turn it over to Saqib, just wanted to highlight for those on the webcast. You can submit a question via using the ask the question feature in the portal. I'd be happy to ask the question on your behalf. Saqib, with that, I'll turn it over to you.

Saqib Islam
SpringWorks Therapeutics, Inc. - CEO & Director

Thank you, Anupam. We appreciate you and the JPM team providing us with an opportunity once again to present at your conference and appreciate you getting up at 4:30 in the morning to do it. It's a pleasure to be here this morning to share the SpringWorks story ahead of what we believe will be a pivotal year for the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot